Beasley, Allen, Crow, Methvin, Portis & Miles, P.C.

A brand of the anesthetic propofol is being recalled by the Food and Drug Administration (FDA) because the injectable emulsion may contain particulate matter that could potentially impede blood flow and lead to serious health issues such as stroke, respiratory failure, kidney failure, liver failure, heart attack and/or stroke. The recall includes 85 lots of Hospira, Inc. brand Liposyn™ II 10%, Liposyn II 20%, Liposyn III 10%, Liposyn III 20%, Liposyn III 30% and 73 lots of Propofol Injectable Emulsion 1% products that begin with the lot numbers 79 and 80. The affected lots were distributed between July 2009 and October 2009.

Read the rest of this entry »

The Food and Drug Administration (FDA) is investigating certain types of medical devices made by Hospira Inc. and Abbott Nutrition after 122 reports of sparking, charring and fires from the power cords used with the devices. The announcement follows a recall announcement and FDA warning last August on some medical devices made by Hospira Inc. because of faulty electrical cords that could lead to serious injury or death.

Read the rest of this entry »

Hospira Inc. is recalling some medical devices because of faulty electrical cords that carry a potential risk of electrical shock, delay in setup and therapy, interruption of therapy, device failure and fires which may also occur in an oxygen-rich environment. Depending on the device and the therapy, these failures may lead to serious injury or death.

Read the rest of this entry »